Search results for "LEVULINIC ACID"

showing 10 items of 35 documents

A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminol…

2018

Background: Basal cell carcinoma (BCC) represents the most common nonmelanoma skin cancer worldwide, affecting mainly adult, fair-skinned individuals. The World Health Organization distinguishes aggressive and nonaggressive forms, of which prototypical variants of the latter are primary nodular and superficial BCC. Objective: To demonstrate noninferiority of BF-200 ALA (a nanoemulsion gel containing 5-aminolaevulinic acid) compared with MAL (a cream containing methyl aminolaevulinate) in the treatment of nonaggressive BCC with photodynamic therapy (PDT). Noninferiority of the primary efficacy variable (overall patient complete response 12 weeks after last PDT) would be declared if the mean …

Malemedicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentSkin CreamPhotodynamic therapyDermatologyAdministration Cutaneouslaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineRandomized controlled trialMethyl aminolevulinatelawCarcinomaHumansMedicineBasal cell carcinomaAgedSkinPhotosensitizing Agentsbusiness.industryActinic keratosisAminolevulinic AcidMiddle Agedmedicine.diseaseDermatologyClinical trialTreatment OutcomePhotochemotherapyCarcinoma Basal Cell030220 oncology & carcinogenesisFemaleSkin cancerbusinessmedicine.drugBritish Journal of Dermatology
researchProduct

Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia

2005

Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) has proven to be safe and effective in patients with early neoplasia in Barrett's esophagus. However, long-term results in patients with high-grade intraepithelial neoplasia (HGIN) or with early cancer are still lacking.The aim of the study was to evaluate the efficacy of ALA-PDT and the survival of patients with early Barrett's neoplasia. ALA-PDT was carried out in 66 patients. Protoporphyrin IX induced by oral administration of ALA (60 mg/kg body weight orally applied 4-6 hours before PDT) was used as the photosensitizer. Acid suppression was maintained in all patients.Between September 1996 and September 2002, 667 patients with …

Malemedicine.medical_specialtyTime FactorsEsophageal Neoplasmsmedicine.medical_treatmentPhotodynamic therapyAdenocarcinomaSeverity of Illness IndexGastroenterologyDisease-Free SurvivalBarrett EsophagusGermanyInternal medicineHumansMedicineRadiology Nuclear Medicine and imagingEsophagusSurvival rateAgedNeoplasm StagingRetrospective StudiesIntraepithelial neoplasiaPhotosensitizing Agentsbusiness.industryGastroenterologyCancerAminolevulinic AcidMiddle Agedmedicine.diseaseSurvival RateTreatment Outcomemedicine.anatomical_structurePhotochemotherapyEsophagectomyHigh Grade Intraepithelial NeoplasiaAdenocarcinomaFemalebusinessPrecancerous ConditionsFollow-Up StudiesGastrointestinal Endoscopy
researchProduct

In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid

1998

Several malignant tissues synthesize endogenous porphyrins after exposure to 5-aminolevulinic acid (5-ALA). The present experiments have been designed to elucidate whether the C6 glioma cell, a model cell for human malignant glioma, similarly synthesizes porphyrins when exposed to 5-ALA, and whether specific synthesis occurs when C6 cells are inoculated into rat brains to form a tumor. In this situation the blood-brain barrier may interfere with 5-ALA availability, and spreading of porphyrins with edema outside the tumor may occur. Flow cytometry is used to determine the course of cell volume and porphyrin fluorescence intensities in cultured C6 cells which are incubated in 1 mM 5-ALA. For …

Malemedicine.medical_treatmentCellBiophysicsProtoporphyrinsPhotodynamic therapyBiologyFlow cytometrychemistry.chemical_compoundIn vivoGliomaTumor Cells CulturedmedicineAnimalsHumansRadiology Nuclear Medicine and imagingRats WistarPhotosensitizing AgentsRadiationRadiological and Ultrasound Technologymedicine.diagnostic_testProtoporphyrin IXAminolevulinic AcidGliomamedicine.diseaseMolecular biologyIn vitroRatsDisease Models Animalmedicine.anatomical_structurechemistryImmunologyChoroid plexusJournal of Photochemistry and Photobiology B: Biology
researchProduct

The unique structure of complete lipopolysaccharide isolated from semi-rough Plesiomonas shigelloides O37 (strain CNCTC 39/89) containing (2S)-O-(4-o…

2013

The complete structure of semi-rough lipopolysaccharide (SR-LPS) of Plesiomonas shigelloides CNCTC 39/89 (serotype O37) has been investigated by (1)H and (13)C NMR spectroscopy, matrix-assisted laser-desorption/ionization time-of-flight MS, and chemical methods. The following structure of the single unit of the O-antigen has been established: [formula see text] in which α-D-Lenp is (2S)-O-(4-oxopentanoic acid)-α-D-Glcp residue which has not been found in nature. The absolute configuration of oxopentanoic acid moiety in α-d-Lenose residue was determined by NOESY experiment combined with molecular modeling (MM2 force field). The decasaccharide core is substituted at C-4 of the β-D-Glcp residu…

Models MolecularMolecular modelStereochemistryMolecular Sequence DataAnalytical chemistryDisaccharideBiochemistryAnalytical Chemistrychemistry.chemical_compoundResidue (chemistry)GlucosidesCarbohydrate ConformationMoietybiologyOrganic ChemistryAbsolute configurationO AntigensGeneral MedicineCarbon-13 NMRbiology.organism_classificationLevulinic AcidsCarbohydrate SequencechemistryPlesiomonas shigelloidesPlesiomonasTwo-dimensional nuclear magnetic resonance spectroscopyCarbohydrate Research
researchProduct

With a Little Help from My Friends: The Role of Intraoperative Fluorescent Dyes in the Surgical Management of High-Grade Gliomas

2018

High-grade gliomas (HGGs) are the most frequent primary malignant brain tumors in adults, which lead to death within two years of diagnosis. Maximal safe resection of malignant gliomas as the first step of multimodal therapy is an accepted goal in malignant glioma surgery. Gross total resection has an important role in improving overall survival (OS) and progression-free survival (PFS), but identification of tumor borders is particularly difficult in HGGS. For this reason, imaging adjuncts, such as 5-aminolevulinic acid (5-ALA) or fluorescein sodium (FS) have been proposed as superior strategies for better defining the limits of surgical resection for HGG. 5-aminolevulinic acid (5-ALA) is i…

Oncologymedicine.medical_specialtyReviewlcsh:RC321-571Resection03 medical and health scienceschemistry.chemical_compoundHigh-grade glioma0302 clinical medicineGliomaInternal medicineYELLOW 560 filterMedicinefluorescein sodiumastrocytomalcsh:Neurosciences. Biological psychiatry. NeuropsychiatryProtoporphyrin IXSettore MED/27 - Neurochirurgiabusiness.industryGeneral NeuroscienceglioblastomaAstrocytomaMultimodal therapymedicine.diseaseFluorescenceextent of resectionchemistry5-aminolevulinic acid030220 oncology & carcinogenesisPrimary Malignant Brain TumorsSodium fluoresceinbusinesshigh-grade gliomas030217 neurology & neurosurgeryBrain Sciences
researchProduct

Hexyl aminolevulinate, 5‐aminolevulinic acid nanoemulsion and methyl aminolevulinate in photodynamic therapy of non‐aggressive basal cell carcinomas:…

2020

Background In the photodynamic therapy (PDT) of non‐aggressive basal cell carcinomas (BCCs), 5‐aminolevulinic acid nanoemulsion (BF‐200ALA) has shown non‐inferior efficacy when compared with methyl aminolevulinate (MAL), a widely used photosensitizer. Hexyl aminolevulinate (HAL) is an interesting alternative photosensitizer. To our knowledge, this is the first study using HAL‐PDT in the treatment of BCCs. Objectives To compare the histological clearance, tolerability (pain and post‐treatment reaction), and cosmetic outcome of MAL, BF‐200 ALA, and low‐concentration HAL in the PDT of non‐aggressive BCCs. Methods Ninety‐eight histologically verified non‐aggressive BCCs met the inclusion criter…

Skin Neoplasmsmedicine.medical_treatmentPhotodynamic therapyGastroenterologylaw.invention030207 dermatology & venereal diseases0302 clinical medicineMethyl aminolevulinateRandomized controlled trialnon-aggressive basal cell carcinomalawTOPICAL IMIQUIMODProspective Studies10. No inequalityProspective cohort studyPhotosensitizing AgentsSisätaudit - Internal medicinePAINkarsinoomat3. Good healthTreatment OutcomeInfectious Diseasesphotodynamic therapyTolerabilityFluorouracil030220 oncology & carcinogenesisBOWENS-DISEASEmedicine.symptommedicine.drugmedicine.medical_specialtyBiolääketieteet - Biomedicine3122 Cancersmethyl aminolevulinateEUROPEAN GUIDELINESDermatologySINGLE-BLINDLesion03 medical and health scienceshexyl aminolevulinatenon‐aggressive basal cell carcinomaSyöpätaudit - CancersInternal medicineparasitic diseasesMANAGEMENTmedicineCarcinomaHumansANESTHESIAbusiness.industryAminolevulinic Acidmedicine.disease5‐aminolevulinic acid nanoemulsionFLUOROURACILPROTOPORPHYRIN IX FORMATIONfotodynaaminen hoitoPhotochemotherapyCarcinoma Basal Cell5-aminolevulinic acid nanoemulsionbusinessSKINJournal of the European Academy of Dermatology and Venereology
researchProduct

Carbons from second generation biomass as sustainable supports for catalytic systems

2018

Abstract In this study activated carbons were produced from the wood of three different wood species (pine, birch, spruce). The resulting activated carbons were characterized in bulk for ash content, carbon content (elemental analyses), specific surface area, and pore size distribution, and at the surface by measuring the autogenerated pH and studying their structure by XPS. All the samples presented high surface areas and appeared to be mesoporous materials (mesopores >80%). The carbons were then used as support for AuPt nanoparticles and tested in the liquid phase oxidation of glycerol (GLY) and in the hydrogenation of levulinic acid (LA), two important chemicals from cellulose-based biom…

carbon supported catalystsbiomassaCarboxylic acidchemistry.chemical_elementlevulinic acid hydrogenation02 engineering and technology010402 general chemistry01 natural sciencesCatalysisCatalysischemistry.chemical_compoundkatalyytitactivated mesoporous carbonsSpecific surface areaglycerol oxidationLevulinic acidOrganic chemistryCelluloseta116ta215chemistry.chemical_classificationGeneral Chemistry021001 nanoscience & nanotechnologyGVL production0104 chemical scienceschemistryaktiivihiili0210 nano-technologyMesoporous materialSelectivityCarbonCatalysis Today
researchProduct

β-(3,6,9-Trimethyl-9-xanthenyl)propionic acid

2007

The title compound, C19H20O3, was obtained, among other condensation products, from the reaction of meta-cresol and levulinic acid. The pyrane ring closure does not alter significantly the environment of the ethereal linkage in comparison with diaryl ethers. The deformations of the endocyclic valence angles in the benzene rings, centred on the C atoms substituted with alkyl groups, is greater than expected. The mol­ecular packing is influenced by O—H⋯O hydrogen bonds, leading to centrosymmetric dimers.

chemistry.chemical_classificationchemistry.chemical_compoundValence (chemistry)chemistryHydrogen bondStereochemistryLevulinic acidGeneral Materials ScienceGeneral ChemistryCondensed Matter PhysicsBenzeneMedicinal chemistryAlkylActa Crystallographica Section E Structure Reports Online
researchProduct

Enhanced Heterogeneous Catalytic Conversion of Furfuryl Alcohol into Butyl Levulinate

2014

We study the catalytic condensation of furfuryl alcohol with 1-butanol to butyl levulinate. A screening of several commercial and as-synthesized solid acid catalysts shows that propylsulfonic acid-functionalized mesoporous silica outperforms the state-of-the-art phosphotungstate acid catalysts. The catalyst is prepared via template-assisted sol-gel polycondensation of TEOS and MPTMS. It gives 96 % yield (and 100 % selectivity) of butyl levulinate in 4h at 110 °C. Reaction profiles before and after a hot filtration test confirm that the active catalytic species do not leach into the solution. The catalyst synthesis, characterization, and mode of operation are presented and discussed. Sour ca…

inorganic chemicalsCondensation polymerGeneral Chemical EngineeringesterificationNiobiumHeterogeneous catalysisCatalysisCatalysisFurfuryl alcoholalcoholschemistry.chemical_compoundEnvironmental ChemistryOrganic chemistryGeneral Materials ScienceFuransbiomassorganic chemicalsCondensationMesoporous silicasolid acidsSilicon DioxideLevulinic AcidsGeneral Energyheterogeneous catalysischemistryYield (chemistry)ZeolitesPolystyrenesSulfonic AcidsSelectivityChemSusChem
researchProduct

Easy Method for the Transformation of Levulinic Acid into Gamma-Valerolactone Using a Nickel Catalyst Derived from Nanocasted Nickel Oxide

2019

Different nickel catalysts have been tested for the transformation of levulinic acid into &gamma

inorganic chemicalsMaterials scienceHydrogenValerolactonechemistry.chemical_element02 engineering and technology010402 general chemistrylcsh:Technology01 natural sciencesArticleHydrothermal circulationCatalysischemistry.chemical_compoundLevulinic acidNickelotorhinolaryngologic diseasesLevulinic acidheterocyclic compoundsGeneral Materials ScienceNanocastinglcsh:Microscopylcsh:QC120-168.85lcsh:QH201-278.5lcsh:Torganic chemicalsNickel oxideNon-blocking I/O021001 nanoscience & nanotechnology0104 chemical sciencesgamma-ValerolactoneNickelHydrothermal reactionChemical engineeringchemistrylcsh:TA1-2040lcsh:Descriptive and experimental mechanicslcsh:Electrical engineering. Electronics. Nuclear engineeringHigh temperature waterlcsh:Engineering (General). Civil engineering (General)0210 nano-technologylcsh:TK1-9971Materials
researchProduct